Is Localized Scleroderma Caused by Borrelia burgdorferi?

被引:8
作者
Zinchuk, Alexander N. [1 ]
Kalyuzhna, Lidiya D. [2 ]
Pasichna, Iryna A. [3 ]
机构
[1] Danylo Halytsky Natl Med Univ, Dept Infect Dis, Pekarska St 54, UA-79010 Lvov, Ukraine
[2] Natl Med Acad Postgrad Educ, Dept Dermatol, Kiev, Ukraine
[3] Danylo Halytsky Natl Med Univ, Dept Therapy, UA-79010 Lvov, Ukraine
关键词
Antibody; benzyl penicillin; Lyme disease; scleroderma; SCLEROSUS-ET-ATROPHICUS; LICHEN-SCLEROSUS; NO EVIDENCE; SPIROCHETAL ORIGIN; MORPHEA; DNA; LESIONS; INFECTION; ERYTHEMA; MIGRANS;
D O I
10.1089/vbz.2016.2004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Despite considerable achievements in the study of localized scleroderma, the etiology of the disease has not been investigated completely. Borrelia burgdorferi-the agent of Lyme disease-is suggested to be one of the possible etiological factors of localized scleroderma. However, among scientists, this hypothesis is quite controversial. We have conducted investigations of the level of IgM and IgG class antibodies to B. burgdorferi in the serum of patients with localized scleroderma. To rationally substantiate the role of B. burgdorferi in the occurrence of localized scleroderma, thirty-two patients with localized scleroderma treated at an in-patient department were examined. The level of anti-Borrelia antibodies was determined in ELISA. Diagnostic levels of IgM and/or IgG were detected in 18.8% of patients with localized scleroderma, which is more than in the population (p < 0.01). Positive levels of anti-Borrelia antibodies in patients with localized scleroderma confirm the borreliosis nature of the disease, requiring conduction of complex antimicrobial treatment.
引用
收藏
页码:577 / 580
页数:4
相关论文
共 25 条
[1]  
ABERER E, 1987, ACTA DERM-VENEREOL, V67, P225
[2]  
AlonsoLlamazares J, 1997, ACTA DERM-VENEREOL, V77, P299
[3]  
Braun-Falco O, 2004, DERMATOLOGY VENEREOL, P785
[4]  
Breier F, 1996, BRIT J DERMATOL, V134, P285, DOI 10.1111/j.1365-2133.1996.tb07615.x
[5]   LYMPHOPROLIFERATIVE RESPONSES TO BORRELIA-BURGDORFERI IN PATIENTS WITH ERYTHEMA MIGRANS, ACRODERMATITIS CHRONICA ATROPHICANS, LYMPHADENOSIS BENIGNA CUTIS, AND MORPHEA [J].
BUECHNER, SA ;
LAUTENSCHLAGER, S ;
ITIN, P ;
BIRCHER, A ;
ERB, P .
ARCHIVES OF DERMATOLOGY, 1995, 131 (06) :673-677
[6]  
CANALES IP, 1990, REV CLIN ESP, V186, P320
[7]   Role of Borrelia burgdorferi in the pathogenesis of morpheal/scleroderma and lichen sclerosus et atrophicus: A PCR study of thirty-five cases [J].
DeVito, JR ;
Merogi, AJ ;
Vo, T ;
Boh, EE ;
Fung, HK ;
Freeman, SM ;
Cockerell, C ;
Stewart, K ;
Marrogi, AJ .
JOURNAL OF CUTANEOUS PATHOLOGY, 1996, 23 (04) :350-358
[8]   BORRELIA-BURGDORFERI DNA IS UNDETECTABLE BY POLYMERASE CHAIN-REACTION IN SKIN-LESIONS OF MORPHEA, SCLERODERMA, OR LICHEN-SCLEROSUS-ET-ATROPHICUS OF PATIENTS FROM NORTH-AMERICA [J].
DILLON, WI ;
SAED, GM ;
FIVENSON, DP .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (04) :617-620
[9]   Morphoea:: a manifestation of infection with Borrelia species? [J].
Eisendle, K. ;
Grabner, T. ;
Zelger, B. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (06) :1189-1198
[10]  
Espinoza-León Fabiola, 2006, Invest. clín, V47, P283